Product Liability

Social Media Addiction & Youth Mental Health School District MDL

Social Media Addiction & Youth Mental Health School District MDL — Product Liability class action lawsuit

Case Overview

This landmark multidistrict litigation consolidates thousands of personal injury lawsuits filed by minors and their families alongside hundreds of school district and municipal claims, all alleging that the major social media platforms — Meta (Facebook/Instagram), Snap (Snapchat), TikTok (ByteDance), and Google (YouTube) — knowingly designed their products with addictive features that exploit the developing neurology of children and adolescents. Plaintiffs point to internal documents, including Meta's own internal research ('Facebook knows Instagram is toxic for teen girls'), showing that defendants were aware their platforms caused serious psychological harm to young users yet concealed this information and continued deploying engagement-maximizing algorithms, infinite scroll, and notification systems targeting minors.

The litigation is proceeding on two primary tracks in MDL No. 3047: personal injury claims from thousands of individual minors and families alleging specific harms including depression, anxiety, eating disorders, self-harm, and suicide attempts or completions; and public entity claims from over 700 school districts across the country seeking to recover the enormous costs of addressing the student mental health crisis the platforms are alleged to have caused, including counseling services, mental health staff, and curriculum changes. Judge Yvonne Gonzalez Rogers has allowed most claims to proceed past the motion-to-dismiss stage, rejecting the platforms' Section 230 immunity defenses on products liability grounds. Bellwether trials are expected in 2025, and several states' attorneys general have also filed parallel enforcement actions. This is widely considered the most consequential social media accountability litigation in U.S. history.

Who May Qualify

Minor children or young adults (and their parents/guardians) who developed documented mental health conditions — including depression, anxiety, eating disorders, self-harm, or suicidal ideation — that are substantially linked to compulsive or addictive use of Instagram, Facebook, Snapchat, TikTok, or YouTube. School districts and municipalities may also pursue claims for public costs associated with the youth mental health crisis.

Frequently Asked Questions

Can I sue Instagram or TikTok if my child developed depression or an eating disorder?

Yes, thousands of families have already filed suit in the MDL. To have a strong claim, it generally helps to show that your child was a regular user of one or more platforms, developed a documented mental health condition during or after heavy use, and that there is a plausible link between the platform use and the condition. Attorneys handling MDL cases offer free consultations.

What has the court decided so far in the social media addiction MDL?

Judge Gonzalez Rogers largely denied the platforms' motions to dismiss in late 2023, ruling that many product liability, negligence, and state consumer protection claims can proceed. The court rejected Meta, Snap, TikTok, and Google's arguments that Section 230 of the Communications Decency Act shielded them from liability for design defect claims. Bellwether trials are anticipated in 2025.

Is there a deadline to join the social media youth mental health lawsuit?

There is no single universal deadline, but statutes of limitations apply and vary by state — generally 2 to 3 years from the date the injury was discovered. Because many victims are minors, the clock may be tolled until they turn 18. It is strongly advisable to consult an attorney as soon as possible to preserve your right to file.

Related Cases

Ozempic / Mounjaro GI Injury (Gastroparesis & Bowel Obstruction) Products Liability MDL — Product Liability class action lawsuit

Ozempic / Mounjaro GI Injury (Gastroparesis & Bowel Obstruction) Products Liability MDL

Current
Product Liability
Patients who used GLP-1 receptor agonist drugs Ozempic (semaglutide) and Mounjaro (tirzepatide) for weight loss or diabetes management allege they suffered severe gastrointestinal injuries — including gastroparesis (stomach paralysis), bowel obstruction, and intestinal ileus — that were not adequately disclosed in the drugs' warnings.
Victoza (Liraglutide) Lawsuit: Vision Loss (NAION) Claims — Product Liability class action lawsuit

Victoza (Liraglutide) Lawsuit: Vision Loss (NAION) Claims

Current
Product Liability
Victoza (liraglutide) lawsuits claim that Novo Nordisk failed to warn patients about the risk of non-arteritic anterior ischemic optic neuropathy (NAION), a condition causing sudden vision loss. Users of the GLP-1 diabetes drug allege that the manufacturer did not adequately disclose the potential eye damage risks.
B. Braun Aesculap Knee Replacement Defective Device Lawsuit — Product Liability class action lawsuit

B. Braun Aesculap Knee Replacement Defective Device Lawsuit

Current
Product Liability
A lawsuit against B. Braun alleges that its Aesculap knee replacement devices have serious design defects causing metallosis, early device failure, and complications requiring revision surgeries. The company is accused of concealing these defects from regulators while continuing to promote the device.